New stem cell method may eliminate need for blood donations to maintain platelet supply

February 13, 2014

Platelets, whose primary function is to prevent bleeding, are vital for treating various forms of trauma and blood diseases. However, they can only be obtained through blood donations at present. Researchers reporting online February 13 in the Cell Press journal Cell Stem Cell recently found a way to create platelets without the need for donated blood, an advance that could possibly erase supply shortages and ensure platelet treatments for all who need them.

The supply of donated , which have a short shelf life and must be kept at room temperature, is often insufficient to meet clinical needs. In addition, while transfused platelets do not typically need to be immune-matched to patients, repeated transfusion of unmatched platelets leads to an immune reaction that eventually renders patients unresponsive to platelet .

To address these limitations, investigators from Japan developed a strategy to derive functional platelets from human induced . Induced pluripotent stem cells can be generated from various types of cells in the body, and they can in turn be coaxed to develop into nearly any other cell type. In the current study, the approach involved genetically manipulating such to become stable immortalized lines of platelet-producing cells called megakaryocyte progenitors.

The megakaryocyte progenitors could produce large quantities of platelets with clotting capabilities that were similar to those of donated platelets. Unlike freshly donated platelets, though, the immortalized megakaryocyte progenitors could be expanded and frozen for long-term storage.

"Here we established a method to achieve the long-term self-replication of megakaryocyte progenitors as an immortalized cell line, which could eventually contribute to large-scale cultivation and production of platelets," says senior author Dr. Koji Eto of Kyoto University and the University of Tokyo.

Explore further: Researchers tap into a new and potentially better source of platelets for transfusion

More information: Cell Stem Cell, Nakamura et al.: "Expandable megakaryocyte cell lines enable clinically-applicable generation of platelets from human induced pluripotent stem cells." dx.doi.org/10.1016/j.stem.2014.01.011

Related Stories

Method for manufacturing patient-specific human platelets

November 22, 2010

Skin cells from humans can be revamped into pro-clotting cells called platelets, according to a study published on November 22 in the Journal of Experimental Medicine. Patients with diseases causing thrombocytopenia—platelet ...

Insights into type 2B von Willebrand disease

November 25, 2013

In response to blood vessel damage, von Willebrand factor (vWF) binds to the exposed extra cellular matrix, recruits platelets to the site of injury, and activates platelets, which promotes thrombis formation. Patients with ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.